The Myeloma Beacon

Independent, up-to-date news and information for the multiple myeloma community.
Home page Deutsche Artikel Artículos Españoles

Forums

Discussion about insurance, treatment costs, and patient assistance programs

Combination drug therapy and insurance

by Courtney CH on Tue Feb 21, 2012 1:53 pm

I was recently surprised when my Myeloma Doc indicated to me that it might be tough to get insurance approval for adding Thalidomide to the regimin of Velcade and Dex that I have been on. I had not heard of this being a problem before . It has me concerned whether it will be problematic to be able to use other less routine combinations. I was under impression that using combinations of drugs was main source for optimism for those of us who have relapsed a few times.. I am also concerned about how viable it will be to use FDA aproved drugs "off label". I am assuming drugs without FDA aproval will require participating in a clinical trial. I would appreciate feedback on what experience people here (patients, caregivers, physicians) have had with insurance companies with regard to paying for drug combinations. Thanks Joe

Courtney CH

Re: Combination drug therapy and insurance

by Ron Harvot on Wed Feb 22, 2012 3:27 pm

I have been on combination therapy since I started treatment in Feb of 2009. I have been on Velcade, Revlimid, Dex and Aredia. I have had no issues with my insurance as I only have an annual deductible and small co-pays. ($14/month for 21 day supply - 28 day cycle of 10 mg Revlimid.) The Dex is only a $10 copy for 40 4 mg pills. Velcade is incorporated into the charge I get for the blood work that is done each time I get a Velcade shot. (Insurance covers 100% once I meet my annual deductible which includes all Dr. Visits).

I am fortunate that I have been able to work full time and maintained my very good employer coverage. I note that medicare pays much less and some employer plans are not as generous as mine.

Ron

Ron Harvot


Return to Insurance & Patient Assistance Programs